Miltenyi Biotec
Miltenyi Biotec home - back to start page
Miltenyi BiotecMiltenyi Biotec
Miltenyi Biotec
Miltenyi Biotec
Miltenyi Biotec
navigation Sample preparation
navigation Cell separation
navigation Cell analysis
navigation Cell culture
navigation Molecular applications
Miltenyi Biotec
Miltenyi Links
Miltenyi Home
MACS Cytokines
MACS Cell Analysis
Tissue Dissociation
Neuroscience
Genomic Services
Miltenyi Biotec
  • Gentle: viable single-cell suspensions from solid tumor tissue
  • Reproducible: user-independent dissociation for consistent results
  • Safe: closed system ensures sterile sample handling
CSC sample preparation that is reliable, reproducible, and rapid
The analysis of tumor stem cell populations requires effective methods for tissue dissociation. The gentleMACS™ Dissociator reliably dissociates the extracellular matrix and cell adhesion components of tumor masses to obtain viable single cell suspensions. Specialized automated programs optimize the dissociation of human and mouse tumors for reproducible results in a short time.
Protocols Products MB MB MB
The human tumor tissue dissociation protocol has been developed for the preparation of tumor cells from human primary melanoma tissue or melanoma metastases. Furthermore, it has been successfully used for the dissociation of human primary carcinoma and ovarian carcinoma tissues. Our protocol for implanted mouse tumors was developed for the preparation of tumor cells from mouse melanomas, carcinomas, or pancreatic tumors.
Preparation of single-cell suspensions from human tumors
Dissociation of implanted mouse tumors
Preparation of single-cell suspensions from human tumor tissues
Tumor Dissociation
Miltenyi Biotec
Search this website
Services
Customer login
Contact
Newsletter
Favorites / Prices
Request prices or add products to your favorite list.
Details
MACS Stem Cell newsletter
Stay current with important developments in stem cell research by subscribing to Stem Cell Updates.
Meetings and congresses
4th Intl. Tübingen-Symposium on Pediatric Solid Tumors
February 16-18
Tübingen, Germany
Molecular Medicine Tri-Conference
February 19-23
San Francisco, CA, USA
more...
 
 
 
 
 
 
 
© 1999 - 2012 Miltenyi Biotec ¦ Terms & conditions ¦ Legal notes
Miltenyi Biotec website